These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28848192)

  • 1. Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis.
    Bauer D; Busch M; Pacheco-López G; Kasper M; Wildschütz L; Walscheid K; Bähler H; Schröder M; Thanos S; Schedlowski M; Heiligenhaus A
    Neuroimmunomodulation; 2017; 24(2):87-99. PubMed ID: 28848192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Udaka K; Ueno H
    Immunogenetics; 2005 Jun; 57(5):337-43. PubMed ID: 15902435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
    Takeda A; Hasegawa E; Fukuhara T; Hirakawa S; Yamada H; Yang Y; Yoshimura T; Hisatomi T; Oshima Y; Yoshida H; Sonoda KH; Ishibashi T
    Exp Eye Res; 2014 Aug; 125():107-13. PubMed ID: 24929202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
    Escobar T; Yu CR; Muljo SA; Egwuagu CE
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of P2X
    Takeda A; Yamada H; Hasegawa E; Arima M; Notomi S; Myojin S; Yoshimura T; Hisatomi T; Enaida H; Yanai R; Kimura K; Ishibashi T; Sonoda KH
    Jpn J Ophthalmol; 2018 May; 62(3):398-406. PubMed ID: 29572578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis.
    Agarwal RK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1999 Mar; 162(5):2648-54. PubMed ID: 10072507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation.
    Exton MS; von Hörsten S; Schult M; Vöge J; Strubel T; Donath S; Steinmüller C; Seeliger H; Nagel E; Westermann J; Schedlowski M
    J Neuroimmunol; 1998 Aug; 88(1-2):182-91. PubMed ID: 9688340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis.
    Sonoda KH; Yoshimura T; Takeda A; Ishibashi T; Hamano S; Yoshida H
    Int Immunol; 2007 Jan; 19(1):93-8. PubMed ID: 17118967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionally distinct IFN-γ
    Chen YH; Eskandarpour M; Gondrand A; Zhang X; Gu R; Galatowicz G; Lightman SL; Calder VL
    Eur J Immunol; 2020 Dec; 50(12):1941-1951. PubMed ID: 32652562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine taste-immune associative learning.
    Niemi MB; Pacheco-López G; Kou W; Härting M; del Rey A; Besedovsky HO; Schedlowski M
    Brain Behav Immun; 2006 Nov; 20(6):527-31. PubMed ID: 16631347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.
    Fang J; Fang D; Silver PB; Wen F; Li B; Ren X; Lin Q; Caspi RR; Su SB
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3092-9. PubMed ID: 20107166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.